A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects
Clinical trial NCT05875259 · COMPLETED
Trial details
- NCT number
- NCT05875259
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-13
- Primary completion
- 2023-06-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.